Dr Brandon Lucke-Wold | traumatic brain injury | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Brandon Lucke-Wold | traumatic brain injury | Best Researcher Award 🏆

Student at  Harbin Engineering University ,China
🎓

Brandon P. Lucke-Wold is an emerging leader in the field of neurosurgery and research, specializing in traumatic brain injury, subarachnoid hemorrhage, ischemic stroke, and neurosurgery simulation. His interdisciplinary approach combines cutting-edge research with clinical practice, aimed at advancing treatment modalities for neurotrauma. 🌟

 

Professional Profile 

  • Scopus Profile

🎓 Education

Brandon earned his Bachelor’s degree in Neuroscience, with a minor in Chemistry, from Baylor University, graduating Magna Cum Laude in 2011. He pursued further education at West Virginia University Health Science Center, completing both his MD/PhD program and a Master’s in Clinical and Translational Science with a perfect GPA of 4.0. Currently, he is undergoing Neurosurgery Residency Training at the University of Florida, with expected completion in 2025. Additionally, he has participated in prestigious fellowships, including the R25 Research Fellow program and the Endovascular Fellowship at the University of Florida. 🎓

🏢 Work Experience

Throughout his career, Brandon has gained extensive experience through various research and clinical roles. He has served as a research fellow at the University of Florida, focusing on the intersection of clinical practice and scientific inquiry. His ongoing involvement in the Neurosurgeon Scientist Training Program underscores his commitment to integrating scientific research into neurosurgical practice. 🔬

🧬 Skills

Brandon possesses a diverse skill set that encompasses laboratory research, clinical diagnostics, and innovative treatment approaches for neurotrauma. His expertise in lab animal tracking, pharmaceutical treatment for neurological conditions, and laser mapping techniques for glioma diagnosis are particularly noteworthy. He excels in both technical proficiency and collaborative research, making him a valuable asset in any scientific endeavor. 🛠️

Awards and Honors 🏆

Brandon has been recognized for his outstanding contributions to the field of neurosurgery and research. Notable accolades include the Neurosurgery Research and Education Foundation Research Fellowship Grant and the Young Clinician Investigator Award, both for the period 2024-2025. His work has also led to the submission of patents for novel treatments in the realm of traumatic encephalopathy and subarachnoid hemorrhage. 🏆

Membership 🤝

Brandon is an active member of several professional organizations, including the Academy of Leadership and Civic Engagement at Baylor University, reflecting his commitment to leadership and community engagement within the scientific community. His involvement enhances his professional network and fosters collaboration across various disciplines. 🌐

Teaching Experience 📚

As part of his academic journey, Brandon has engaged in teaching and mentorship, fostering the development of future leaders in neurosurgery. His experiences in the Baylor Honors Program and the Baylor Interdisciplinary Core have allowed him to impart knowledge and inspire students to pursue careers in neuroscience and medicine.

🔬 Research Focus

Brandon’s research interests lie at the intersection of neurosurgery and translational science, with a particular emphasis on traumatic brain injury and subarachnoid hemorrhage. His innovative projects aim to develop new diagnostic tools and therapeutic strategies, contributing to improved patient outcomes in neurotrauma. By leveraging advanced techniques in simulation and diagnostics, he strives to bridge the gap between laboratory discoveries and clinical application. 🔍🧠

📚 Publication 

  • Blockchain-Based Applications in Neurological Surgery
    • World Neurosurgery, 2024-11
    • DOI: 10.1016/j.wneu.2024.08.086
  • Quantum Computing in the Realm of Neurosurgery
    • World Neurosurgery, 2024-10
    • DOI: 10.1016/j.wneu.2024.09.131
  • Emerging and Current Biologics for the Treatment of Intracranial Aneurysms
    • Biologics, 2024-09-26
    • DOI: 10.3390/biologics4040022
  • Diagnostic and Prognostic Role of NLR in Testicular Cancer
    • Exploration of Targeted Anti-tumor Therapy, 2024-09-19
    • DOI: 10.37349/etat.2024.00270
  • Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer’s Disease
    • Biomedicines, 2024-09-17
    • DOI: 10.3390/biomedicines12092113
  • Neurodegenerative Disorders in the Context of Vascular Changes after Traumatic Brain Injury
    • Journal of Vascular Diseases, 2024-09-06
    • DOI: 10.3390/jvd3030025

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at  Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

Scopus 

Education 🎓

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience 💼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills 🧠

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors 🏆

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimer’s Association in Chicago (1998).

Membership 🤝

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience 📚

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus 🔬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving β-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer’s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimer’s Disease-Related Genes—A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimer’s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr. NadiaZikiou | remote sensing | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. NadiaZikiou | remote sensing | Best Researcher Award  🏆

Postdoctoral Research Associate at YIBS and CS department at Yale University , United States🎓

Nadia ZIKIOU is an accomplished researcher and educator specializing in Electronics and remote sensing. With a strong foundation in deep learning and image processing, she currently holds a postdoctoral associate position at Yale University, focusing on transformational environmental science. Her work bridges academia and practical applications, aiming to contribute to advancements in technology and education.

Professional Profile 

🎓 Education

Nadia obtained her Bachelor’s degree in Electrical Engineering and Electronics with honors from Mouloud Maameri University in June 2009. 🎓 She then pursued a Magister in Electronics, graduating in October 2014, focusing on remote sensing. Her Doctorate in Electronics, awarded in 2020 with “Very Honorable” mention, emphasized hyperspectral texture classification and compression, conducted in collaboration with XLIM laboratory in France. 🌍 Currently, she is working as a Postdoctoral associate at Yale University, set to complete her program in July 2024.

🏢 Work Experience

Nadia has accumulated extensive experience in both research and teaching. 💼 Her scientific production includes several international publications and communications, reflecting her expertise in hyperspectral imaging and machine learning applications. Additionally, she has supervised numerous projects for senior technicians and master’s theses, showcasing her leadership in academic settings.

🧬 Skills

Nadia possesses a diverse skill set, including proficiency in deep learning, image processing, and remote sensing techniques. 💡 She is adept at using various software tools and programming languages for data analysis and visualization, enhancing her research capabilities. Her technical expertise is complemented by strong pedagogical skills, allowing her to effectively communicate complex concepts to students.

Awards and Honors

Throughout her academic journey, Nadia has received numerous accolades for her achievements. 🏅 Her degrees were awarded with distinctions, including honors for her Bachelor’s and Doctorate programs, reflecting her commitment to excellence in her field.

🌍 Memberships

Nadia is an active member of several professional organizations related to electronics and remote sensing, which keeps her engaged with the latest advancements and research in her field. 🤝 Her participation in conferences and workshops further enhances her professional network and collaborative opportunities.

📚 Teaching Experience

Nadia’s teaching experience spans over a decade, where she has conducted lectures and practical sessions in various subjects such as digital electronics and microprocessors. 📖 She has successfully guided students through their academic journeys and contributed to their professional development through co-supervision of theses and practical work.

🔬 Research Focus

Her current research focuses on utilizing deep learning techniques for remote sensing applications, particularly in hyperspectral image classification and environmental monitoring. 🔍 Nadia is committed to advancing knowledge in her field, aiming to apply her findings to real-world challenges and improve technological solutions for environmental science.

📚 Publilcation

  • Sentinel-2 data classification for land use land cover mapping in northern Algeria
    • Year: 2023
    • Journal: Algorithms, Technologies, and Applications for Multispectral and Hyperspectral Imaging XXIX
  • Hyperspectral image classification using graph-based wavelet transform
    • Year: 2019
    • Journal: Journal of Remote Sensing
  • Support vector regression-based 3D-wavelet texture learning for hyperspectral image compression

 

 

 

 

Dr Ramón Iglesias-Rey | neuroimaging | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Ramón Iglesias-Rey | neuroimaging | Best Researcher Award 🏆

  Miguel Servet Researcher at Health Research Institute of Santiago de Compostela (IDIS), Spain 🎓

Dr. Ramón Iglesias Rey is a Miguel Servet Researcher at the Fundación IDIS in Spain. He leads the preclinical Magnetic Resonance Unit within the Neuroimaging and Biotechnology Laboratory. His research focuses on the molecular mechanisms of disease using animal models and bioinstrumentation. He co-founded the spin-off company, LINCbiotech, in 2017.

Professional Profile 

🎓 Education

He earned a PhD in Materials Science (2013) and a Physics degree (2006) from the University of Santiago de Compostela.

🏢 Work Experience

Dr. Iglesias has served as a postdoc and research assistant at the University of Santiago and held an international postdoctoral position in Finland (2015).

🧬 Skills

He is skilled in molecular biology, MRI, and bioinstrumentation.

Awards and Honors 🏆

He has multiple patents and co-developed the “Glutamate nanoprobe MR-agent.”

📚 Teaching Experience

Involved in mentoring students in neuroscience and bioengineering.

 

🔬 Research Focus

Dr. Lozupone’s research primarily revolves around Alzheimer’s disease, cognitive frailty, and psychiatric conditions in the elderly. She has published extensively on neurodegenerative diseases, exploring topics such as tau-based therapeutics, antidepressant treatment in dementia, and the genetic factors influencing cognitive disorders. Her multidisciplinary research aims to improve diagnostics, therapeutic interventions, and patient outcomes in cognitive aging.

Conclusion 

Dr. Madia Lozupone is an outstanding candidate for the Cognitive Aging Excellence Award due to her extensive research contributions in Alzheimer’s disease, cognitive frailty, and late-life psychiatric disorders. Her leadership roles in several high-profile research projects, combined with her international editorial positions, make her a leader in the field of cognitive aging. By continuing to expand her collaborative research efforts and increasing her public engagement, Dr. Lozupone could further solidify her position as a top expert in cognitive aging.

📚 Publilcation 

  • Assessment of Mannitol-Induced Chronic Blood–Brain Barrier Dysfunction In Vivo Using Magnetic Resonance
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype
    • Year: 2024
    • Journal: Neurology
  • Edoxaban Treatment in a Post-Infarction Experimental Model
    • Year: 2024
    • Journal: European Journal of Pharmacology
  • How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke?
    • Year: 2023
    • Journal: Applied Sciences
  • Influence of Temperature Chronobiology on Stroke Outcome
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Fibrin-Targeted Nanoparticles for Finding, Visualizing, and Characterizing Blood Clots in Acute Ischemic Stroke
    • Year: 2022
    • Journal: Pharmaceutics
  • Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
  • Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
  • Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke
    • Year: 2022
    • Journal: Journal of Clinical Medicine

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Amira Boseila | Neuroscience| Best Researcher Award🏆


Lecturer at Sinai University,Egypt🎓

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional Profile 

🎓 Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

🏢 Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

🧬 Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors 🏆

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

🔬 Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

📚 Publication 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

 

Prof Dr. BASSEMSADEK | Neuropharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. BASSEMSADEK | Neuropharmacology | Best Researcher Award 🏆

Pharmacology and Therapeutics at College of Medicine and Health Sciences, United Arab Emirates University🎓

Dr. Bassem Shaban Sadek is a highly accomplished professor specializing in Pharmaceutical Medicinal Chemistry and Neuropharmacology. He is currently a Full Professor in the Department of Pharmacology and Therapeutics at the United Arab Emirates University, with ongoing research collaborations in Germany. His career spans over two decades of academic, research, and professional experience in both Europe and the Middle East.

Professional Profile 

Education

Dr. Sadek earned his Ph.D. in Pharmaceutical Medicinal Chemistry and Drug Design in 1999 from the Free University of Berlin (FUB), where his thesis focused on the development of selective and potent Histamine H3-Receptor Antagonists. He also holds a Bachelor of Pharmacy, which he received in 1994 from FUB.

 Work Experience

Throughout his career, Dr. Sadek has held various academic positions, starting as a Teaching Assistant at the Free University of Berlin, progressing to Assistant Professor roles at universities in the UAE and Germany. Notably, he was the Director of the Pharm-D Program at UAE University from 2015 to 2019. Since 2021, he has been a Full Professor at UAE University and a Research Associate at Heinrich Heine University in Düsseldorf, Germany.

 Skills 

Dr. Sadek has advanced expertise in preclinical research design and medical statistical analysis. He is proficient in statistical software like SPSS and GraphPad Prism, as well as molecular modeling tools such as ChemDraw, MOE, PyMol, and drug-likeness prediction programs. His knowledge extends to data analysis and visualization using Excel and PowerPoint.

Awards & Honors

Dr. Sadek has received numerous prestigious awards, including multiple Distinguished Research Awards for publishing in top international journals, Best Teacher Awards, and the ADEK Award for Research Excellence. His teaching and research have been recognized for excellence in both undergraduate and postgraduate education.

 Membership

He is actively involved in several professional bodies, including the Society for Neuroscience (SfN), the European Histamine Research Society (EHRS), and the German Pharmaceutical Association (DPhG). He also serves on editorial boards for various scientific journals and as a reviewer for major international funding bodies.

 

 Teaching Experience

Dr. Sadek has extensive teaching experience, offering courses in neuropharmacology, pharmacokinetics, and drug design for both undergraduate and postgraduate students. He has supervised numerous graduate theses and research projects, contributing to the academic development of his students.

 Research Focus

His research centers on preclinical drug development targeting neurodegenerative and behavioral disorders. He specializes in histamine H3 receptor antagonists, exploring their potential in treating conditions such as autism, epilepsy, and Alzheimer’s disease. Dr. Sadek employs cutting-edge in vivo and in vitro models to advance neuropharmacological research.

 

📖Publications : 

  • “Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice”
  • “The Microbiota–Gut–Brain Axis and Neurological Disorders: A Comprehensive Review”
  • “Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder”
  • “Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice”
  • “The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice”
  • “Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action”
  • “Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin”
  • “Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder”
  • “Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism”
  • “Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities”

Assist Prof Dr. Farzad Nasiri | Clinical Psychology| Best Researcher Award

Published on by Cognitive Scientist Awards

 Assist Prof Dr. Farzad Nasiri | Clinical Psychology | Best Researcher Award  🏆

University of Kurdistan,IRAN 🎓

Dr. Farzad Nasiri is an Associate Professor at the University of Kurdistan, where he also serves as the Head of the Department of Psychology. With a rich background in clinical and experimental psychology, he has been dedicated to advancing both academic research and therapeutic practice. His professional journey is marked by a strong commitment to psychology and cognitive-behavioral therapy (CBT), particularly in the treatment of anxiety and mood disorders.

 

 

Professional Profile 

🎓 Education

Dr. Nasiri completed his Ph.D. in Psychology in 2019 at Ferdowsi University of Mashhad, following his Master’s (2012) and Bachelor’s degrees (2010) in Clinical Psychology from the University of Tabriz. His academic journey began with a High School Diploma in Experimental Sciences from Shaheed Beheshti School in 2004, highlighting his early dedication to scientific disciplines.

 

🏢 Work Experience

Dr. Nasiri has extensive experience as a university professor, teaching Ph.D., Master’s, and Bachelor’s courses in clinical psychology, cognitive psychology, neuropsychology, and psychotherapy techniques. In addition to his academic roles, he has been a reviewer and editor for various scientific journals, including the Journal of Clinical Psychology and Counseling and the Journal of Medical Sciences.

 

🧬 Skills

Dr. Nasiri’s expertise lies in Cognitive Behavioral Therapy (CBT) and transcranial direct current stimulation (tDCS). He has led workshops on anxiety management and tDCS, and his therapeutic focus centers on mood and anxiety disorders. His extensive research covers mindfulness-based therapies, emotional regulation, and executive functions in psychological disorders.

Awards and Honors 🏆

Throughout his career, Dr. Nasiri has earned exceptional grades, with notable recognition for his research and clinical work. His thesis projects earned the highest distinctions, including a perfect score of 20 for his Ph.D. dissertation under Dr. Ali Mashhadi.

 

🔬 Research Focus

Dr. Nasiri’s research spans cognitive and emotional indices of anxiety, transdiagnostic therapy, and mindfulness-based interventions. He has authored several books and translated works on CBT, chronic pain, insomnia, and autism. His scholarly publications address critical psychological issues, including anxiety disorders, resilience, and emotional regulation strategies.

 

📚 Publilcation 

  • Comparison of executive functions in people with high and low resilience
    Year: 2024 | Journal: Journal of Psychiatric Research
    (Shariati, A., Nasiri, F., Rahmani, F.)
  • A culturally adapted unified protocol for transdiagnostic treatment of anxiety disorders in adolescents (UP-A): A randomized waitlist-controlled trial
    Year: 2024 | Journal: Psychological Medicine
    (Zemestani, M., Ezzati, S., Nasiri, F., Barlow, D.H., Kendall, P.C.)
  • Augmenting the unified protocol with transcranial direct current stimulation: Effects on emotion regulation and executive dysfunction
    Year: 2023 | Journal: Clinical Psychology and Psychotherapy
    (Nasiri, F., Ellard, K.K., Mashhadi, A., Bigdeli, I., Ghanaei-Chamanabad, A.)
  • Premenstrual Syndrome: The Role of Emotion Regulation Strategies and Trait Meta-Mood
    Year: 2022 | Journal: Journal of Rational – Emotive and Cognitive – Behavior Therapy
    (Nasiri, F., Sharifi, S., Mashhadi, A., Sharp, R.)
  • How to Differentiate Generalized Anxiety Disorder from Worry: The Role of Cognitive Strategies
    Year: 2020 | Journal: Journal of Rational – Emotive and Cognitive – Behavior Therapy
    (Nasiri, F., Mashhadi, A., Bigdeli, I., Chamanabad, A.G.)
  • Augmenting the unified protocol for transdiagnostic treatment of emotional disorders with transcranial direct current stimulation in individuals with generalized anxiety disorder and comorbid depression: A randomized controlled trial
    Year: 2020 | Journal: Journal of Affective Disorders
    (Nasiri, F., Mashhadi, A., Bigdeli, I., Chamanabad, A.G., Ellard, K.K.)

 

 

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award 🏆

Poznan University of Medical Sciences, Poland🎓

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional Profile 

 

🎓 Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

🏢 Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors 🏆

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

🔬 Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

Conclusion 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

📚 Publilcation 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimer’s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantation—Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. Przegląd Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-α Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child

 

Dr sandra zaouche | Microbiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr sandra zaouche | Microbiology | Best Researcher Award 🏆

Biotechnology at The Stephan Angeloff Institute of Microbiology-BAS,Bulgaria🎓

This individual is a Senior Assistant Professor specializing in Microbiology with extensive academic and research experience. They currently work at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, in Sofia, Bulgaria. Their career spans over a decade, contributing to both research and teaching in microbiology and microbial biotechnology.

 

Professional Profile 

  • scopus

🎓 Education

They completed their PhD in Microbiology at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences (2008-2013). Prior to this, they obtained an MSc in Microbial Biotechnology from Plovdiv University “Paisii Hilendarski” (2007) and a BSc in Biology and Chemistry from the same university (2005) 🎓📚.They completed their PhD in Microbiology at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences (2008-2013). Prior to this, they obtained an MSc in Microbial Biotechnology from Plovdiv University “Paisii Hilendarski” (2007) and a BSc in Biology and Chemistry from the same university (2005) 🎓📚.

🏢 Work Experience

The individual has held several academic positions, starting as an Assistant Professor and advancing to Senior Assistant Professor at The Stephan Angeloff Institute of Microbiology (2012-present). Their role involves conducting cutting-edge research in microbiology, teaching students, and contributing to the academic community through various scholarly activities 🏫🔬.

🧬 Skills

Their expertise includes microbiological research, microbial biotechnology, laboratory management, and advanced research methodologies. They are proficient in designing experiments, analyzing data, and applying scientific principles to solve complex biological problems 🧪🔍.

Awards and Honors 🏆

Throughout their career, they have received multiple accolades for their contributions to the field of microbiology, reflecting their dedication to advancing scientific knowledge and their commitment to excellence in research and education 🏆✨

🔬 Professional Memberships

They are a member of several prestigious professional societies related to microbiology and biotechnology, staying actively engaged with the scientific community for the exchange of knowledge and innovation 🌐👩‍🔬.

📚 Teaching Experience

With years of experience teaching at the undergraduate and graduate levels, they have mentored and trained numerous students in microbiology and related fields, ensuring they provide a high standard of education and foster a collaborative learning environment 🧑‍🏫👩‍🎓.

🔬 Research Focus

Their primary research interest is in the field of microbial biotechnology, particularly focusing on the application of microorganisms in industrial processes, environmental sustainability, and the development of new biotechnological tools. They aim to explore innovative ways to harness the potential of microbes for solving global challenges 🌱🧬.

📚 Publilcation 

 

Dr Gamze Gök | biochemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Gamze Gök | biochemistry | Best Researcher Award 🏆

Medical biochemist at  Ankara Bilkent City Hospital, Turkey🎓

👩‍🔬 Gamze Gök is a dedicated Medical Biochemist, currently working in the Medical Biochemistry Department at Ankara Bilkent City Hospital, Turkey. Specializing in biochemistry, Gamze has a keen interest in oxidative stress, thiol-disulfide homeostasis, trace elements, and fatty acids. Her research spans across these fields, contributing significantly to the scientific community through numerous publications.

 

Professional Profile 

🎓 Education

🎓 Gamze completed her medical biochemistry specialization in 2021, gaining in-depth knowledge in biochemical processes. She is highly skilled in scientific research, having taken part in numerous national and international studies throughout her academic career.

🏢 Work Experience

🏥 Since completing her specialization, Gamze has been an active researcher at Ankara Bilkent City Hospital. She has played a critical role in 21 published studies on PubMed, covering various biochemistry-related topics and contributing significantly to advancements in medical science.

🧬 Skills

🧪 Core Skills include expertise in oxidative stress markers, thiol-disulfide homeostasis, and the analysis of trace elements and fatty acids. Gamze also excels in methodological approaches to research, formal analysis, and scientific writing. Her collaborative spirit and commitment to innovative biochemistry research are commendable.

Awards and Honors 🏆

🏅 Gamze has been recognized for her contributions to medical biochemistry, having been part of 25 journals indexed in prestigious databases such as SCI and Scopus. Her extensive research involvement has earned her notable mentions in several international forums.

🔬 Professional Memberships

Although Gamze does not currently hold memberships in any professional organizations, her extensive work in collaborative research projects speaks to her professional dedication and ongoing contributions to the medical biochemistry community.

📚 Teaching Experience

Gamze has demonstrated leadership through her mentorship in various research studies. Although not formally engaged in teaching roles, she has shared her knowledge through collaborative efforts and has contributed to the growth of research methodologies in the medical field.

🔬 Research Focus

Gamze’s research focus is on critical biochemical areas such as oxidative stress, thiol-disulfide homeostasis, and fatty acids. She has contributed to the study of glutathione’s role in the development and prognosis of non-muscle-invasive bladder cancer, among other significant biochemistry topics.

 

📚 Publilcation 

  • The Effect of Glutathione on Development and Prognosis in Non-Muscle-Invasive Bladder Cancer
    2024 – Journal of Clinical Medicine, 13(18), 5483
  • Evaluation of Ethanol Test Analysis: The Two Years Experience
    2024 – International Journal of Medical Biochemistry, 7(3), pp. 163–167
  • Assessment of Thiol-Disulfide and Glutathione Homeostasis After Levothyroxine Replacement in Individuals with Autoimmune or Nonautoimmune Hypothyroidism
    2024 – Archives of Endocrinology and Metabolism, 68, e230197
  • Evaluation of Drug Abuse Test Analysis: One Year Experience
    2024 – International Journal of Medical Biochemistry, 7(2), pp. 67–72
  • Evaluation of the Dynamic Thiol/Disulfide Homeostasis in Patients with Chronic Venous Insufficiency
    2024 – Journal of Vascular Surgery: Venous and Lymphatic Disorders, 12(1), 101689
  • Validation of Assays for Measurement of Oxidant Compounds in Saliva of Pigs: Thiobarbituric Acid Reactive Substances (TBARS), Carbonyl, and Reactive Oxygen Species (ROS)
    2023 – Research in Veterinary Science, 165, 105069
  • The Effects of Cerium Oxide on Sevoflurane Anesthesia and Its Relationship to Renal Injury in Rats
    2023 – Gazi Medical Journal, 34(3), pp. 283–287
  • The Relationship Between Vitamin-D Deficiency and Protein Oxidation Among Obese Children
    2023 – Fetal and Pediatric Pathology, 42(4), pp. 599–613
  • An Evaluation of Thiol/Disulphide Homeostasis and HDL Values in Patients with Cholelithiasis: A Prospective Case-control Study
    2022 – Journal of the College of Physicians and Surgeons Pakistan, 32(4), pp. 424–429
  • Is Dynamic Thiol/Disulphide Homeostasis Associated with the Prognosis of Geriatric Patients with Sepsis in the Intensive Care Unit?
    2022 – Turk Geriatri Dergisi, 25(4), pp. 495–503